5-ALA to help see brain tumors during surgery in children
Part of Brain & nervous system, Cancer clinical trials.
This trial tests whether a drug called 5-ALA, given before surgery, can help surgeons see and remove pediatric brain tumors more completely. It may be an option for children with specific types of brain tumors that are planned for removal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 2 and 17 years old, and have a brain tumor that needs surgery.
- Your tumor type is one of the approved types, such as astrocytoma, medulloblastoma, or ependymoma.
- You are not pregnant or breastfeeding.
- You have no history of porphyria (a blood disorder) or allergies to 5-ALA or similar drugs.
- Your blood counts and organ function are within normal limits (checked by your doctor).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special dye called 5-ALA can help surgeons see tumor tissue more clearly during brain tumor surgery. If you are having surgery for a high-grade glioma or another brain tumor, you may be able to join and help improve surgical precision.
This trial tests a treatment that targets tumor blood-vessel growth to slow or shrink relapsed/progressive brain tumors in children. It may help if standard options are no longer working.
This trial tests a drug called 5-ALA that helps surgeons see tumor cells more clearly during surgery. It is for children and teens with high-grade brain tumors who are having surgery to remove the tumor.
This trial compares two surgical techniques for removing malignant brain tumors: one using a special dye (5-ALA) that makes tumor cells glow under a blue light, versus the standard white light surgery. The goal is to see if the dye-guided approach helps surgeons remove more of the tumor safely.
This study is testing whether a special dye called 5-ALA can help doctors see brain tumors more clearly during surgery. You may be able to join if you are scheduled for surgery to remove a suspected high-grade glioma.
This trial uses artificial intelligence to analyze MRI scans and help doctors identify the type of brain tumor in children. It aims to improve treatment planning by providing a non-invasive way to predict the tumor subtype before surgery.
Hear when a new Pediatric Brain Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.